ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Cardiovascular Endocrinology
Effects of moderate to vigorous physical activity on the associations of insulin resistance surrogate with incident cardiovascular disease and all-cause mortality: a cohort study from the UK Biobank
Provisionally accepted- 1Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 2Yueyang Central Hospital Department of Endocrinology, Yueyang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background Moderate to vigorous physical activity (MVPA) and insulin resistance (IR) are associated with cardiovascular disease (CVD). It remains unclear whether different durations of MVPA can modify the associations of triglyceride glucose-waist height ratio (TyG-WHtR) index, a surrogate for IR, with incident CVD and all-cause mortality, and particularly whether MVPA levels beyond guideline recommendations can provide additional benefit. Methods This cohort study included 299,928 adults from UK Biobank study who were free of prevalent CVD at baseline and had complete data on MVPA, the TyG-WHtR index, and covariates. Cox proportional hazards model was used to assess the independent and joint associations of MVPA and TyG-WHtR with incident CVD and all-cause mortality. A product term of MVPA (<150, 150-299, 300-599, and ≥600 min/wk) and TyG-WHtR (tertiles) was included in the model to assess the multiplicative interaction. Results During a median follow-up of 13.8 and 13.6 years, 27,342 CVD cases and 21,258 deaths were observed. MVPA demonstrated a reverse J-shaped association with incident CVD, with a cut-off point at 261.71 min/wk, whereas an L-shaped association was observed for all-cause mortality with risk reduction plateauing at 217.00 min/wk. Elevated TyG-WHtR showed positive associations with increased risks of incident CVD and all-cause mortality. No significant interaction was found on incident CVD, whereas interaction effect was observed between 150-299 min/wk MVPA and TyG-WHtR tertile 2 on all-cause mortality (HR for interaction, 0.89; 95%CI, 0.81-0.97; P for interaction=0.012). Compared to the reference group (<150 min/wk MVPA and TyG-WHtR tertile 3), all other combined groups were associated with lower risks. Among participants with MVPA levels of 150-299, 300-599 and ≥600 min/wk, the extent of risk reduction for the outcomes was similar. Conclusions Our findings highlight the importance of engaging in guideline-recommended MVPA (150-299 min/wk) to reduce all-cause mortality risk, particularly among individuals with moderate IR (TyG-WHtR 7.01-8.03), who are more susceptible to its benefits. Furthermore, the protective effects of higher levels of MVPA against IR-related risks were consistent with those of guideline-recommended MVPA.
Keywords: Moderate to vigorous physical activity, Insulin Resistance, Triglyceride glucose-waist height ratio index, cardiovascular disease, All-cause mortality
Received: 19 Sep 2025; Accepted: 23 Oct 2025.
Copyright: © 2025 Zhu, Yao, Yan and Ke. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Qinmei Ke, ke6666@hust.edu.cn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
